BOZZA, NICOLE
BOZZA, NICOLE
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine
2021-01-01 Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M.
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR
2019-01-01 Castelli, R; Bozza, N; Cavazzoni, A; Bonelli, M; Vacondio, F; Ferlenghi, F; Callegari, D; Silva, C; Rivara, S; Lodola, A; Digiacomo, G; Fumarola, C; Alfieri, R; Petronini, Pg; Mor, M.
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma
2021-01-01 Castelli, R.; Taranto, S.; Furiassi, L.; Bozza, N.; Marseglia, G.; Ferlenghi, F.; Rivara, S.; Retini, M.; Bedini, A.; Spadoni, G.; Matarazzo, S.; Ronca, R.; Presta, M.; Mor, M.; Giacomini, A.
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.
2019-01-01 Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg.
Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88
2021-01-01 Sacco, A.; Federico, C.; Giacomini, A.; Caprio, C.; Maccarinelli, F.; Todoerti, K.; Favasuli, V.; Anastasia, A.; Motta, M.; Russo, D.; Rossi, G.; Bozza, N.; Castelli, R.; Neri, A.; Ronca, R.; Cattaneo, C.; Tucci, A.; Mor, M.; Presta, M.; Roccaro, A. M.
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors
2016-01-01 Castelli, Riccardo; Giacomini, Arianna; Anselmi, Mattia; Bozza, Nicole; Vacondio, Federica; Rivara, Silvia; Matarazzo, Sara; Presta, Marco; Mor, Marco; Ronca, Roberto
Targeting FGFR1 pathway in non small cell lung cancer both in vitro and in vivo
2017-01-01 Cretella, D; Fumarola, C; la Monica, S; Alfieri, R; Bozza, N; Castelli, R; Mor, M; Petronini, Pg; Cavazzoni, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine | 1-gen-2021 | Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M. | |
| Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR | 1-gen-2019 | Castelli, R; Bozza, N; Cavazzoni, A; Bonelli, M; Vacondio, F; Ferlenghi, F; Callegari, D; Silva, C; Rivara, S; Lodola, A; Digiacomo, G; Fumarola, C; Alfieri, R; Petronini, Pg; Mor, M. | |
| Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma | 1-gen-2021 | Castelli, R.; Taranto, S.; Furiassi, L.; Bozza, N.; Marseglia, G.; Ferlenghi, F.; Rivara, S.; Retini, M.; Bedini, A.; Spadoni, G.; Matarazzo, S.; Ronca, R.; Presta, M.; Mor, M.; Giacomini, A. | |
| Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. | 1-gen-2019 | Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg. | |
| Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88 | 1-gen-2021 | Sacco, A.; Federico, C.; Giacomini, A.; Caprio, C.; Maccarinelli, F.; Todoerti, K.; Favasuli, V.; Anastasia, A.; Motta, M.; Russo, D.; Rossi, G.; Bozza, N.; Castelli, R.; Neri, A.; Ronca, R.; Cattaneo, C.; Tucci, A.; Mor, M.; Presta, M.; Roccaro, A. M. | |
| Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors | 1-gen-2016 | Castelli, Riccardo; Giacomini, Arianna; Anselmi, Mattia; Bozza, Nicole; Vacondio, Federica; Rivara, Silvia; Matarazzo, Sara; Presta, Marco; Mor, Marco; Ronca, Roberto | |
| Targeting FGFR1 pathway in non small cell lung cancer both in vitro and in vivo | 1-gen-2017 | Cretella, D; Fumarola, C; la Monica, S; Alfieri, R; Bozza, N; Castelli, R; Mor, M; Petronini, Pg; Cavazzoni, A. |